EVE Health Group Limited (AU:EVE) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
EVE Health Group has announced the sale of its ‘Robyndale’ property through its subsidiary Jenbrook to a subsidiary of the renewable energy company Cape Byron Power for $2,125,000, with key conditions including due diligence and FIRB approval. The proceeds will be reinvested to support the growth of Meluka Australia and to seek further acquisitions in the health and wellness sector. This strategic divestment aims to bolster EVE’s portfolio and market presence in the health and wellness industry.
For further insights into AU:EVE stock, check out TipRanks’ Stock Analysis page.